tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market
PCRX
Pacira Pharmaceuticals
RESEARCH TOOLSreports

Pacira Pharmaceuticals (PCRX) Stock News & Sentiment

383 Followers
Pacira Earnings Call Highlights Margin Gains And Growth
Premium
Company Announcements
Pacira Earnings Call Highlights Margin Gains And Growth
1M ago
PCRX
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
Premium
Ratings
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
1M ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PCRX
Pacira Biosciences (PCRX) Securities Lawsuit Dismissed by New Jersey Federal Court
Premium
Class Action
Pacira Biosciences (PCRX) Securities Lawsuit Dismissed by New Jersey Federal Court
2M ago
PCRX
Pacira BioSciences adds seasoned leader to board
Premium
Company Announcements
Pacira BioSciences adds seasoned leader to board
2M ago
8K
PCRX
Pacira Biosciences: Exparel-Led Growth and Discounted Valuation Support Attractive Risk–Reward and Buy Rating
Premium
Ratings
Pacira Biosciences: Exparel-Led Growth and Discounted Valuation Support Attractive Risk–Reward and Buy Rating
3M ago
PCRX
Pacira: Maintaining Buy on Durable Non-Opioid Growth and Share Buybacks Despite Near-Term Revenue Softness
Premium
Ratings
Pacira: Maintaining Buy on Durable Non-Opioid Growth and Share Buybacks Despite Near-Term Revenue Softness
3M ago
PCRX
More PCRX News >

PCRX News on the Web

Pacira price target lowered to $25 from $27 at Barclays
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX), Pacira Pharmaceuticals (PCRX) and Alnylam Pharma (ALNY)
TipRanks News
Neutral
J.P. Morgan Sticks to Their Sell Rating for Pacira Pharmaceuticals (PCRX)
TipRanks News
Neutral
Insider Shake-Up at Pacira Pharmaceuticals Sparks Fresh Investor Buzz
TipRanks News
Neutral
Insider Sell: Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
GuruFocus News
Neutral
Pacira Biosciences Inc at Barclays Global Healthcare Conference Transcript
GuruFocus News
Neutral
Doma Perpetual nominates three to Pacira board
TipRanks News
Bearish
Pacira (PCRX) Grants Inducement Awards to New Employees
GuruFocus News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PCRX’s Media Buzz Sentiment?
Currently, no data Available
What is PCRX’s weekly average amount of articles?
Currently, no data Available
What is PCRX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week